{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T06:17:40Z","timestamp":1743056260157,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071629130"},{"type":"electronic","value":"9781071629147"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2914-7_11","type":"book-chapter","created":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T04:01:09Z","timestamp":1672545669000},"page":"151-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the Efficacy of Immune Checkpoint Inhibitors in Preclinical Tumor Models"],"prefix":"10.1007","author":[{"given":"Celia","family":"Jacoberger-Foissac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,1]]},"reference":[{"key":"11_CR1","first-page":"252","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Cell Mol Immunol 12:252\u2013264","journal-title":"Cell Mol Immunol"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","volume":"44","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, V\u00e9tizou M, Daill\u00e8re R et al (2016) Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity 44:1255\u20131269","journal-title":"Immunity"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.3390\/ijms21114118","volume":"21","author":"DS Chulpanova","year":"2020","unstructured":"Chulpanova DS, Kitaeva KV, Rutland CS et al (2020) Mouse tumor models for advanced cancer immunotherapy. Int J Mol Sci 21:4118","journal-title":"Int J Mol Sci"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nm.3853","volume":"21","author":"SE Gould","year":"2015","unstructured":"Gould SE, Junttila MR, de Sauvage FJ (2015) Translational value of mouse models in oncology drug development. Nat Med 21:431\u2013439","journal-title":"Nat Med"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ejca.2003.11.021","volume":"40","author":"MC Bibby","year":"2004","unstructured":"Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40:852\u2013857","journal-title":"Eur J Cancer"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"C-P Day","year":"2015","unstructured":"Day C-P, Merlino G, Van Dyke T (2015) Preclinical mouse cancer models: a maze of opportunities and challenges. Cell 163:39\u201353","journal-title":"Cell"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4049\/jimmunol.173.3.2143","volume":"173","author":"MH Kershaw","year":"2004","unstructured":"Kershaw MH, Jackson JT, Haynes NM et al (2004) Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer. J Immunol 173:2143\u20132150","journal-title":"J Immunol"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, Blake SJ, Yong MCR et al (2016) Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov 6:1382\u20131399","journal-title":"Cancer Discov"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1158\/1078-0432.CCR-18-2641","volume":"25","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Hoefsmit EP, Smyth MJ et al (2019) The promise of neoadjuvant immunotherapy and surgery for cancer treatment. Clin Cancer Res 25:5743\u20135751","journal-title":"Clin Cancer Res"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41591-020-0829-0","volume":"26","author":"JM Versluis","year":"2020","unstructured":"Versluis JM, Long GV, Blank CU (2020) Learning from clinical trials of neoadjuvant checkpoint blockade. Nat Med 26:475\u2013484","journal-title":"Nat Med"},{"key":"11_CR11","first-page":"e51967","volume":"96","author":"B Kocat\u00fcrk","year":"2015","unstructured":"Kocat\u00fcrk B, Versteeg HH (2015) Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth. J Vis Exp 96:e51967","journal-title":"J Vis Exp"},{"key":"11_CR12","first-page":"e1581530","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu J, O\u2019Donnell JS, Yan J et al (2019) Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome. Onco Targets Ther 8:e1581530","journal-title":"Onco Targets Ther"}],"container-title":["Methods in Molecular Biology","The Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2914-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T04:43:48Z","timestamp":1672548228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2914-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071629130","9781071629147"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2914-7_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"1 January 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}